1.Discovery of a Fluoroquinolone-Resistant Serratia marcescens Clinical Isolate without Quinolone Resistance-Determining Region Mutations.
Haifei YANG ; Guosheng CHEN ; Jun CHENG ; Yanyan LIU ; Lifen HU ; Ying YE ; Jiabin LI
Annals of Laboratory Medicine 2014;34(6):487-488
No abstract available.
Aged
;
Anti-Bacterial Agents/*pharmacology
;
Bacterial Proteins/genetics
;
Drug Resistance, Bacterial/*genetics
;
Fluoroquinolones/*pharmacology
;
Humans
;
Male
;
Microbial Sensitivity Tests
;
Mutation
;
Serratia Infections/*diagnosis/microbiology
;
Serratia marcescens/*drug effects/genetics/isolation & purification
2.The Emergence of the 16S rRNA Methyltransferase RmtB in a Multidrug-Resistant Serratia marcescens Isolate in China.
Xue Jiao MA ; Hai Fei YANG ; Yan Yan LIU ; Qing MEI ; Ying YE ; Hong Ru LI ; Jun CHENG ; Jia Bin LI
Annals of Laboratory Medicine 2015;35(1):172-174
No abstract available.
Aged, 80 and over
;
Anti-Bacterial Agents/pharmacology
;
Bacterial Proteins/*genetics
;
China
;
Drug Resistance, Multiple, Bacterial
;
Humans
;
Male
;
Methyltransferases/*genetics
;
Microbial Sensitivity Tests
;
RNA, Ribosomal, 16S/genetics/metabolism
;
Serratia marcescens/drug effects/*enzymology/*genetics/isolation & purification
;
Urinary Tract Infections/diagnosis/microbiology
3.Risk Factors for Mortality in Patients with Serratia marcescens Bacteremia.
Sun Bean KIM ; Yong Duk JEON ; Jung Ho KIM ; Jae Kyoung KIM ; Hea Won ANN ; Heun CHOI ; Min Hyung KIM ; Je Eun SONG ; Jin Young AHN ; Su Jin JEONG ; Nam Su KU ; Sang Hoon HAN ; Jun Yong CHOI ; Young Goo SONG ; June Myung KIM
Yonsei Medical Journal 2015;56(2):348-354
PURPOSE: Over the last 30 years, Serratia marcescens (S. marcescens) has emerged as an important pathogen, and a common cause of nosocomial infections. The aim of this study was to identify risk factors associated with mortality in patients with S. marcescens bacteremia. MATERIALS AND METHODS: We performed a retrospective cohort study of 98 patients who had one or more blood cultures positive for S. marcescens between January 2006 and December 2012 in a tertiary care hospital in Seoul, South Korea. Multiple risk factors were compared with association with 28-day all-cause mortality. RESULTS: The 28-day mortality was 22.4% (22/98 episodes). In a univariate analysis, the onset of bacteremia during the intensive care unit stay (p=0.020), serum albumin level (p=0.011), serum C-reactive protein level (p=0.041), presence of indwelling urinary catheter (p=0.023), and Sequential Oran Failure Assessment (SOFA) score at the onset of bacteremia (p<0.001) were significantly different between patients in the fatal and non-fatal groups. In a multivariate analysis, lower serum albumin level and an elevated SOFA score were independently associated with 28-day mortality [adjusted odds ratio (OR) 0.206, 95% confidential interval (CI) 0.044-0.960, p=0.040, and adjusted OR 1.474, 95% CI 1.200-1.810, p<0.001, respectively]. CONCLUSION: Lower serum albumin level and an elevated SOFA score were significantly associated with adverse outcomes in patients with S. marcescens bacteremia.
Adult
;
Aged
;
Aged, 80 and over
;
Anti-Bacterial Agents/therapeutic use
;
Bacteremia/drug therapy/microbiology/*mortality
;
Cross Infection/mortality
;
Female
;
Humans
;
Intensive Care Units
;
Male
;
Middle Aged
;
Multiple Organ Failure
;
Republic of Korea/epidemiology
;
Retrospective Studies
;
Risk Factors
;
Serratia Infections/diagnosis/drug therapy/*mortality
;
Serratia marcescens/drug effects/*isolation & purification
;
Severity of Illness Index
;
Survival Rate
;
Time Factors
;
Treatment Outcome